DEXCOM INC's ticker is and the CUSIP is 252131AH0. A total of 19 filers reported holding DEXCOM INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $56,270,993 | +23.1% | 17,990,000 | +11.5% | 0.00% | 0.0% |
Q1 2023 | $45,694,279 | -55.9% | 16,140,000 | -57.1% | 0.00% | 0.0% |
Q4 2022 | $103,710,924 | +186.7% | 37,630,000 | +106.0% | 0.00% | +50.0% |
Q3 2022 | $36,176,000 | +19.8% | 18,265,000 | +11.6% | 0.00% | 0.0% |
Q2 2022 | $30,195,000 | -44.4% | 16,365,000 | -6.0% | 0.00% | -33.3% |
Q1 2022 | $54,345,000 | -24.4% | 17,415,000 | -20.8% | 0.00% | 0.0% |
Q4 2021 | $71,859,000 | -5.3% | 21,990,000 | -3.7% | 0.00% | -25.0% |
Q3 2021 | $75,873,000 | +29.4% | 22,840,000 | +1.3% | 0.00% | +33.3% |
Q2 2021 | $58,655,000 | +11.1% | 22,540,000 | -5.5% | 0.00% | 0.0% |
Q1 2021 | $52,774,000 | +11.0% | 23,840,000 | +13.3% | 0.00% | 0.0% |
Q4 2020 | $47,555,000 | -11.0% | 21,040,000 | -0.2% | 0.00% | -25.0% |
Q3 2020 | $53,415,000 | -0.9% | 21,090,000 | -3.0% | 0.00% | 0.0% |
Q2 2020 | $53,903,000 | +28.8% | 21,740,000 | -9.8% | 0.00% | 0.0% |
Q1 2020 | $41,849,000 | +8.9% | 24,100,000 | -6.9% | 0.00% | +33.3% |
Q4 2019 | $38,433,000 | – | 25,900,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Elequin Capital, LP | 11,771,000 | $26,632,270 | 5.17% |
Calamos Advisors LLC | 30,006,000 | $67,881,974 | 0.35% |
CAPSTONE INVESTMENT ADVISORS, LLC | 5,000,000 | $11,302,500 | 0.05% |
D. E. Shaw & Co., Inc. | 10,000,000 | $23,351,070 | 0.02% |
UBS ASSET MANAGEMENT AMERICAS LLC | 23,000,000 | $52,692,310 | 0.02% |
BNP PARIBAS FINANCIAL MARKETS | 1,035,000 | $2,337,030 | 0.00% |
LOOMIS SAYLES & CO L P | 9,739 | $909 | 0.00% |
MORGAN STANLEY | 2,500,000 | $5,648,750 | 0.00% |
FMR LLC | 6,019,000 | $13,590,902 | 0.00% |
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 200,000 | $451,600 | 0.00% |